Business
Why the Resonance Health (ASX:RHT) share price is shooting 39% higher today
The Resonance Health Limited (ASX: RHT) share price is shooting the lights out today. This comes after the company announced it has received a 510(k) clearance from the United States Food and Drug Administration (FDA) for its HepaFat-AI software.
At the time of writing, the Resonance Health share price is up 38.7% to 21.5 cents. In comparison, the All Ordinaires Index (ASX: XAO) is up 0.7% to 6,969 points.
What’s driving the Resonance Health share price?
The Resonance Health share price is surging today following the company’s positive FDA clearance announcement.
According to Resonance Health, the FDA has cleared the pathway for the company to begin commercialisation for its HepaFat-AI technology.
HepaFat-AI is a medical…
-
Noosa News24 hours agoThe grey backstreet of Brisbane’s Fortitude Valley where Arnie the missing dog was found dead in his owner Nathan McKeown’s black ute
-
General7 hours agoGymnastics club in Berwick shuts down following child safety complaint
-
Noosa News22 hours agoSeven key takeaways from the Queensland probe’s first week
-
General22 hours agoKhawaja causes chaos, Starc and Stokes star as batters collapse — five quick hits from Ashes first Test day one